Lyme neuroborreliosis

Current Opinion in Neurology

Volumn 11, Issue 3, 1998, Pages 253-258

  Haass, Anton ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; DOXYCYCLINE;

BACTERIAL VIRULENCE; BORRELIA BURGDORFERI; BORRELIA INFECTION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; LYME DISEASE; NEUROLOGIC DISEASE; ORAL DRUG ADMINISTRATION; PERIPHERAL NEUROPATHY; REVIEW; SIDE EFFECT; STRAIN DIFFERENCE;

HUMANS; INCIDENCE; LYME DISEASE; NERVOUS SYSTEM DISEASES; NEUROPSYCHOLOGICAL TESTS; SYNDROME; UNITED STATES;

EID: 0031810222     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199806000-00011     Document Type: Review

References (35)

1. Buchwald A. Ein Fall von diffuser idiopatischer Hautatrophie. Vischr Derm 1883; 15:533-536.
2. Younger DS. Lyme Disease: an historical perspective. Semin Neurol 1999; 17:69.
3. Garin C, Bujadoux C. Paralysic par les liques. J Med. Lyon 1922; 71:765-767.
4. Bannwarth A. Chronische lymphocytäre Meningitis, entzündliche Polyneuritis und "Rheumatismus". Ein Beitrag zum Problem "Allergie und Nervensystem" in zwei Teilen. Arch. Psychiat. Nervenkr 1941; 113:284-376.
5. Schaltenbrand G. Chronische aseptische Meningitis. Nervenarzt 1949; 20:433-442.
6. Haass A, Treib J. Neurologic manifestation and classification of Borreliosis. Infection 1996; 24:467-469.
7. Steere A, Malawista Sensibilität, Snydman DR, Shope RECHTS, Andiman WA, Ross MR, Steele FM. Lyme arthritis. An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977; 20:7-17.
8. Kaplan RF, Jones-Woodward L. Lyme encephalopathy: a neuro•psychological perspective. Semin Neurol 1997; 17:31-37. These interesting investigations suggest a neurologic basis to Lyme encephalopathy with CNS infection and a reactive depression in Lyme encephalopathy without CNS infection.
9. Shapiro ED, Seltzer EG. Lyme disease in children. Semin Neurol 1997; 17:39-44.
10. Hauser U, Lehnert G, Lobentanzer R, Wilske B. Interpretation criteria for •• standardized western blots for three european species of Borrelia burgdorferi sensu lato. J Clin Microbiol 1997; 35:1433-1444. This fundamental paper described criteria for performance, analysis and interpretation of standardized Western blot for three European species of B.b. sensu lato.
11. Dressler F, Ackermann R, Steere AC. Antibody responses to the three genomic groups of borrelia burgdoferi in European lyme borreliosis. JID 1994; 169:313-318.
12. Halperin JJ. Neuroborreliosis: central nervous system involvement. Semin Neurol 1997; 17:19-24.
13. Schutzer SE, Coyle PK, Krupp LB, Deng ZD, Belman AL, Dattwyler R, • Luft BJ. Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease. J Clin Invest 1997; 100:763-767. Immunoglobulin M OspA provides a new marker for CNS infection in neuroborreliosis.
14. Dattwyler RJ, Luft BJ, Kunkel MJ, Finkel MF, Wormser GP, Rush TJ, et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med 1997; 337:289-294.
15. Eckman MH, Steere AC, Kalish RA, Pauker SG. Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. N Engl J Med 1997; 337:357-363.
16. Nutritional Center for Infection Disease, CDC. Lyme disease: United States, 1996. JAMA 1997; 278:112
17. Agger WA, Case KL. Clinical comparison of borreliacidal-antibody test with indirect immunofluorescence and enzyme-linked immunosorbent assays for diagnosis of Lyme disease. Mayo Clin Proc 1997; 72: 510-514.
18. Oksi J, Kalimo H, Marttila RJ, Marjamäki M, Sonninen P, Nikoskelainen J, Viljanen MK. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 1996; 119:2143-2154.
19. England JD, Bohm RP, Roberts ED, Philipp MT. Lyme neuroborreliosis in the rhesus monkey. Semin Neurol 1997; 17:53-56.
20. England JD, Bohm RP, Roberts ED, Philipp MT. Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol 1997; 41:375-384.
21. Halperin JJ. Neuroborreliosis. Am J Med 1995; 98:52S-59S.
22. Maimone D, Villanova M, Stanta G, Bonin S, Malandrini A, Guazzi GC, Annunziata P. Detection of Borrelia burgdorferi DNA and complement membrane attack complex deposits in the sural nerve of a patient with chronic polyneuropathy and tertiary Lyme Disease. Muscle Nerve 1997; 20:969-975.
23. Hemmer B, Glockner FX, Kaiser R, Lucking CH, Deuschi G. Generalized motor neuron disease as an unusual manifestation of Borrelia burgdorferi infection. J Neurol Neurosurg Psychiatry 1997; 63:257-258.
24. Kindstrand E, Nilsson BY, Hovmark A, Pirskanen R, Asbrink E. Peripheral neuropathy in Acrodermatitis chronica atrophicans: a late Borrelia manifestation. Acta Neurol Scand 1997; 95:338-345.
25. Curless RG, Schatz NJ, Bowen BC, Rodriguez Z, Ruiz A. Lyme neuroborreliosis masquerading as a brainstem tumor in a 15-year-old. Pediatr Neurol 1996; 15:258-260.
26. Strobino BA, Williams CL, Abid S, et al. Lyme disease and pregnancy outcome: Prospective study of two thousand prenatal patients. Am J Obstet Gynecol 1993; 169:367-375.
27. Gerber MA, Zalneraitis EL. Childhood neurologic disorders and Lyme disease during pregnancy. Pediatr Neurol 1994; 11:41-43.
28. Coleman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH, Benach JL. • Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 1997; 89:1111-1119. Host plasminogen interacts with the B. burgdorferi and induces dissemination of the organism in the tick.
29. Habicht GS, Katona LINKS, Benarch JL. Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J Infect Dis 1991; 164:568-574.
30. Pachner AR, Amemiya K, Delaney E, O'Neill T, Hughes CAN, Zhang WF. Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis. Neurology 1997; 49:147-152.
31. Ebnet K, Brown KD, Siebenlist UK, Simon MM, Shaw S. Borrelia •• burgdorferi activates nuclear factor-kappa B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J Immunol 1997; 158:3285-3292. The described results indicate that B. burgdorferi is a potent inducer of chemokines which are required for leukocyte recruitment and regulation of inflammatory process.
32. Eckman MH, Steere AC, Kalish RA, Pauker SG. Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. N Engl J Med 1997; 337:357-363.
33. Dattwyler RJ, Luft BJ, Kunkel MJ, Finkel MF, Wormser GP, Rush TJ, et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med 1997; 337:289-294.
34. Golde WT, Piesman J, Dolan MC, Kramer M, Hauser P, Lobet Y, et al. Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 1997; 65:882-889.
35. Zhang W, Stehle T, Museteanu C, Siebers A, Gern L, Kramer M, et al. •• Therapeutic passive vaccination against chronic Lyme disease in mice. Proc Natl Acad Sci USA 1997; 94:12533-12538. A new OspC-based vaccine is introduced, which provides complete resolution of disease and infection, independent of the clinical stage.